Cargando…

Re-Evaluate Fusion Genes in Prostate Cancer

BACKGROUND: Thousands of gene fusions have been reported in prostate cancer, but their authenticity, incidence, and tumor specificity have not been thoroughly evaluated, nor have their genomic characteristics been carefully explored. METHODS: We developed FusionVet to dedicatedly validate known fusi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Ting, Lu, Ji, Ma, Tao, Huang, Haojie, Kocher, Jean-Pierre, Wang, Liguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226361/ https://www.ncbi.nlm.nih.gov/pubmed/34234399 http://dx.doi.org/10.1177/11769351211027592

Ejemplares similares

Epidaurus: aggregation and integration analysis of prostate cancer epigenome
por: Wang, Liguo, et al.
Publicado: (2015)

CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer
por: Sun, Rui, et al.
Publicado: (2022)

BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion
por: Blee, Alexandra M., et al.
Publicado: (2016)

Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer
por: He, Yundong, et al.
Publicado: (2018)

CircularLogo: A lightweight web application to visualize intra-motif dependencies
por: Ye, Zhenqing, et al.
Publicado: (2017)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

Fusion in the ETS gene family and prostate cancer
por: Narod, S A, et al.
Publicado: (2008)

Overview of research on fusion genes in prostate cancer
por: Song, Chunjiao, et al.
Publicado: (2020)

A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
por: He, Yundong, et al.
Publicado: (2021)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer()()
por: Chakravarthi, Balabhadrapatruni VSK, et al.
Publicado: (2019)

Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer
por: Schimmelpfennig, Carolin, et al.
Publicado: (2023)

CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model
por: Wang, Liguo, et al.
Publicado: (2013)

Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer
por: Scaravilli, Mauro, et al.
Publicado: (2021)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Protocol to apply spike-in ChIP-seq to capture massive histone acetylation in human cells
por: Wu, Di, et al.
Publicado: (2021)

Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis
por: Ding, Donglin, et al.
Publicado: (2023)

Lineage plasticity-mediated therapy resistance in prostate cancer
por: Blee, Alexandra M, et al.
Publicado: (2019)

Detection of fusion gene transcripts in the blood samples of prostate cancer patients
por: Yu, Yan-Ping, et al.
Publicado: (2021)

ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer
por: Tang, Bo, et al.
Publicado: (2021)

Prognostic value of E‑26 transformation‑specific‑related gene in prostate cancer based on immunohistochemistry analysis
por: Zhang, Yang, et al.
Publicado: (2023)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
por: Dadhania, Vipulkumar, et al.
Publicado: (2022)

Posttranslational Modification of the Androgen Receptor in Prostate Cancer
por: van der Steen, Travis, et al.
Publicado: (2013)

Re: Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Bozkurt, Ibrahim Halil, et al.
Publicado: (2019)

Measure transcript integrity using RNA-seq data
por: Wang, Liguo, et al.
Publicado: (2016)

The impact of pharmacokinetic gene profiles across human cancers
por: Zimmermann, Michael T., et al.
Publicado: (2018)

Evaluation of NOTCH family genes’ expression and prognostic value in prostate cancer
por: Qing, Yunhao, et al.
Publicado: (2022)

Fusion Genes in Prostate Cancer: A Comparison in Men of African and European Descent
por: Morgan, Rebecca, et al.
Publicado: (2022)

In-Fusion BioBrick assembly and re-engineering
por: Sleight, Sean C., et al.
Publicado: (2010)

Correction to: the impact of pharmacokinetic gene profiles across human cancers
por: Zimmermann, Michael T., et al.
Publicado: (2018)

Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer
por: Li, Hongbo, et al.
Publicado: (2020)

Profiling of gene fusion involving targetable genes in Chinese gastric cancer
por: Liu, Zhen-Hua, et al.
Publicado: (2022)

PMEPA1 guards against TGF-β-mediated prostate cancer bone metastasis
por: Blee, Alexandra M., et al.
Publicado: (2016)

Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia
por: Huang, Jin, et al.
Publicado: (2015)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

Optical coding of fusion genes using multicolor quantum dots for prostate cancer diagnosis
por: Lee, Hyojin, et al.
Publicado: (2017)

A re-evaluation of LINE-1 ORF2 expression in LNCaP prostate cancer cells
por: Briggs, Erica M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_29f126o0dn2nj6pc8huaovu8gm